[89Zr]Zr-DFO-TOC: a novel radiopharmaceutical for PET imaging of somatostatin receptor positive neuroendocrine tumors.
Saved in:
| Title: | [89Zr]Zr-DFO-TOC: a novel radiopharmaceutical for PET imaging of somatostatin receptor positive neuroendocrine tumors. |
|---|---|
| Authors: | Sanwick AM; Department of Nuclear Engineering, University of Tennessee, Knoxville, Knoxville, TN, 37996, USA., Haugh KN; Department of Nuclear Engineering, University of Tennessee, Knoxville, Knoxville, TN, 37996, USA., Williams EJ; Department of Nuclear Engineering, University of Tennessee, Knoxville, Knoxville, TN, 37996, USA., Perry KA; Department of Nuclear Engineering, University of Tennessee, Knoxville, Knoxville, TN, 37996, USA., Thiele NA; Chemical Sciences Division, Oak Ridge National Laboratory, Oak Ridge, TN, 37831, USA., Chaple IF; Department of Nuclear Engineering, University of Tennessee, Knoxville, Knoxville, TN, 37996, USA. ichaple@utk.edu. |
| Source: | EJNMMI radiopharmacy and chemistry [EJNMMI Radiopharm Chem] 2024 Dec 18; Vol. 9 (1), pp. 88. Date of Electronic Publication: 2024 Dec 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Open Country of Publication: England NLM ID: 101714628 Publication Model: Electronic Cited Medium: Internet ISSN: 2365-421X (Electronic) Linking ISSN: 2365421X NLM ISO Abbreviation: EJNMMI Radiopharm Chem Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2365-421X |
|---|---|
| DOI: | 10.1186/s41181-024-00320-9 |
